Roaa Biomedical provides deep pharmacological expertise and regulatory foresight to de-risk early-stage development. We guide life science organizations from discovery to clinical readiness, supported by our integrated team of digital, AI, and market localization experts.
Led by a PhD-credentialed pharmacist and medical researcher, ensuring your development pathway is built on sound translational pharmacology and biological validity.
Deep insider expertise navigating the SFDA, ICH, and global regulatory frameworks to ensure your preclinical data translates seamlessly into clinical milestones.
When your project scales, our in-house consultants execute flawlessly—from custom machine learning models to KSA manufacturing feasibility and technology transfer.
Our core practice focuses on foundational science and regulatory strategy, seamlessly integrated with our team's specialized tech, commercial, and local KSA manufacturing capabilities.
Accelerate early-stage programs with targeted gap analysis. We meticulously audit study designs against SFDA and international guidelines to navigate development challenges and achieve IND readiness.
Bespoke scientific advisory focusing on complex mechanisms of action, pharmacokinetics, and target safety to seamlessly bridge the gap between academic discovery and commercial viability.
Drawing on extensive background as a pharmacist and researcher, we provide deep-dive literature reviews, clinical rationale validation, and scientific advisory board support for emerging therapeutics.
Deployment of secure data infrastructure and Software as a Medical Device (SaMD) development. We integrate GDPR/SFDA compliant storage and scalable tech architecture for life sciences.
Led by specialized computer science expertise, we offer bespoke coding, advanced data analysis, and the development of custom machine learning models to accelerate clinical data synthesis.
Strategic guidance for biotechs navigating the UK and MENA commercial landscapes. We provide tailored market access strategies, biopharma marketing frameworks, and sales deployment planning.
Expert guidance on establishing a physical footprint in Saudi Arabia. We provide comprehensive feasibility studies for new manufacturing facilities and high-level administration consultation.
Facilitating complex strategic alliances. We manage technology transfer protocols, intellectual property licensing agreements, and secure reliable supplier agreements for local production.
Deep-dive market research and intelligence specific to the Saudi Arabian landscape. We analyze dynamics across all medication classes to de-risk market entry and optimize product positioning.
Founder & Principal Consultant
(PharmB, MSc, PhD, FHEA)
Dr. Safar founded Roaa Biomedical to bridge the gap between academic scientific discovery and rigorous regulatory reality. With profound expertise as a pharmacist and a PhD-level medical researcher, he provides clients with unparalleled strategic foresight while leading a multidisciplinary firm.
Whether you require foundational pharmacological research, custom AI model development, or a feasibility study for a Saudi manufacturing facility, our consulting team is ready to support your objectives.
Reach out to our leadership team to initiate a consultation:
m.safar@roaa.co.uk